Table 1 Study population characteristics
Type of lesion | |||
|---|---|---|---|
Tumor (N = 96) | Adenoma (N = 27) | P-value | |
Age Mean (SD) | 69.1 (± 10.1) | 69.6 (± 11.6) | 0.73 |
Sex (%) | 0.83 | ||
Male | 56 (58.3%) | 15 (55.6%) | |
Female | 40 (41.7%) | 12 (44.4%) | |
BMI | 0.06 | ||
Mean (SD) | 26.5 (± 5.3) | 24.4 (± 3.8) | |
Missing | 10 (10.4%) | 3 (11.1%) | |
Smoking habit (%) | 0.71 | ||
Never | 44 (45.8%) | 11 (40.7%) | |
Former | 12 (12.5%) | 5 (18.6%) | |
Smoker | 31 (32.3%) | 9 (33.3%) | |
Missing | 9 (9.4%) | 2 (7.4%) | |
Stage (%) | |||
nAA | - | 3 (11.1%) | |
AA | - | 24 (88.9%) | |
0-I | 26 (27.1%) | - | |
II | 32 (33.3%) | - | |
III | 31 (32.3%) | - | |
IV | 3 (3.1%) | - | |
Missing | 4 (4.2%) | - | |
Mucinous status (%) | |||
nmCRC | 70 (56.9%) | - | |
mcCRC | 20 (16.2%) | - | |
mCRC | 6 (4.9%) | - | |
Missing | 27 (22%) | - | |
CMS (%) | |||
CMS1 | 8 (8.3%) | - | |
CMS2 | 27 (28.1%) | - | |
CMS3 | 24 (25.0%) | - | |
CMS4 | 23 (24.0%) | - | |
Missing | 14 (14.6%) | - | |
APC mutational status (%) | 0.24 | ||
Mutated | 55 (57.3%) | 18 (66.7%) | |
Wild-Type | 38 (39.6%) | 6 (22.2%) | |
Missing | 3 (3.1%) | 3 (11.1%) | |
KRAS mutational status (%) | 1.00 | ||
Mutated | 25 (26.0%) | 7 (25.9%) | |
Wild-Type | 68 (70.8%) | 18 (66.7%) | |
Missing | 3 (3.2%) | 2 (7.4%) | |